Literature DB >> 29330663

Human cytomegalovirus-encoded miR-UL112 contributes to HCMV-mediated vascular diseases by inducing vascular endothelial cell dysfunction.

Kai Shen1, Liyun Xu2, Dongdong Chen2, Weiguo Tang3, Yanyan Huang4.   

Abstract

Human cytomegalovirus (HCMV) infection has been linked to the pathogenesis of vasculopathy by inducing dysfunction of vascular cells such as endothelial cells. Hcmv-miR-UL112 is the most well-characterized HCMV-encoded microRNA occurring in the plasma of patients with cardiovascular diseases such as hypertension, while the specific underlying pathophysiological mechanisms are yet to be defined. The current study investigated the effect of hcmv-miR-UL112 on the growth and proliferation of human umbilical vascular endothelial cells (HUVECs); it might also be associated with signaling pathways. An adenovirus vector was designed and synthesized to stably express hcmv-miR-UL112 in HUVECs. Cell Counting Kit-8 results showed that ectopically expressed hcmv-miR-UL112 can significantly increase the proliferation of HUVECs (p < 0.05). Flow cytometry revealed that the S-phase fraction in the cell cycle analysis was raised significantly after overexpression of hcmv-miR-UL112 (p < 0.05). Gene expression profile analysis, using the microarray technology, revealed 303 up-regulated and 62 down-regulated genes in HUVECs by comparing the AD-hcmv-miR-UL112-infected and control groups (p < 0.05 and > 2 fold change). Kyoto Encyclopedia of Genes and Genomes and Reactome Pathway, chosen as the functional annotation categories, were affected by hcmv-miR-UL112 adenovirus vector. The significantly altered pathways mainly include the mitogen-activated protein kinase signaling pathway, cell adhesion molecules, chemokine signaling pathway, cytokine-cytokine receptor interaction, circadian rhythm-mammal, mineral absorption, protein processing in the endoplasmic reticulum, proximal tubule bicarbonate reclamation, vasopressin-regulated water reabsorption, and arachidonic acid metabolism. In conclusion, hcmv-miR-UL112 could serve as a potential biomarker, and the miRNA-mediated regulation of signaling pathways might play significant roles in the physiological effects of hcmv-associated diseases.

Entities:  

Keywords:  Cell cycle; Human umbilical vascular endothelial cells; Microarray; Proliferation; hcmv-miR-UL112

Mesh:

Substances:

Year:  2018        PMID: 29330663     DOI: 10.1007/s11262-018-1532-9

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  34 in total

1.  Identification and characterization of human cytomegalovirus-encoded microRNAs.

Authors:  Finn Grey; Andy Antoniewicz; Edwards Allen; Julie Saugstad; Andy McShea; James C Carrington; Jay Nelson
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Endothelial progenitor cells proliferated via MEK-dependent p42 MAPK signaling pathway.

Authors:  Ferry Sandra; Yudi Her Oktaviono; Mohammad Aris Widodo; Yanni Dirgantara; Angliana Chouw; Djanggan Sargowo
Journal:  Mol Cell Biochem       Date:  2014-11-25       Impact factor: 3.396

Review 3.  Adhesion molecules and their role in vascular disease.

Authors:  C F Krieglstein; D N Granger
Journal:  Am J Hypertens       Date:  2001-06       Impact factor: 2.689

Review 4.  Regulation of MAPKs by growth factors and receptor tyrosine kinases.

Authors:  Menachem Katz; Ido Amit; Yosef Yarden
Journal:  Biochim Biophys Acta       Date:  2007-01-10

5.  Human cytomegalovirus inhibits Akt-mediated eNOS activation through upregulating PTEN (phosphatase and tensin homolog deleted on chromosome 10).

Authors:  Ying H Shen; Lin Zhang; Budi Utama; Jian Wang; Yehua Gan; Xinwen Wang; Jing Wang; Li Chen; Greg M Vercellotti; Joseph S Coselli; Jawahar L Mehta; Xing Li Wang
Journal:  Cardiovasc Res       Date:  2005-11-28       Impact factor: 10.787

6.  microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia.

Authors:  Aldo M Roccaro; Antonio Sacco; Xiaoying Jia; Abdel Kareem Azab; Patricia Maiso; Hai T Ngo; Feda Azab; Judith Runnels; Phong Quang; Irene M Ghobrial
Journal:  Blood       Date:  2010-06-02       Impact factor: 22.113

7.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

8.  Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function.

Authors:  Paraskevi Petrakopoulou; Marion Kübrich; Sinan Pehlivanli; Bruno Meiser; Bruno Reichart; Wolfgang von Scheidt; Michael Weis
Journal:  Circulation       Date:  2004-09-14       Impact factor: 29.690

9.  Cytomegalovirus miRNAs target secretory pathway genes to facilitate formation of the virion assembly compartment and reduce cytokine secretion.

Authors:  Lauren M Hook; Finn Grey; Robert Grabski; Rebecca Tirabassi; Tracy Doyle; Meaghan Hancock; Igor Landais; Sophia Jeng; Shannon McWeeney; William Britt; Jay A Nelson
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

10.  Genome-wide transcriptional profiling reveals microRNA-correlated genes and biological processes in human lymphoblastoid cell lines.

Authors:  Liang Wang; Ann L Oberg; Yan W Asmann; Hugues Sicotte; Shannon K McDonnell; Shaun M Riska; Wanguo Liu; Clifford J Steer; Subbaya Subramanian; Julie M Cunningham; James R Cerhan; Stephen N Thibodeau
Journal:  PLoS One       Date:  2009-06-11       Impact factor: 3.240

View more
  10 in total

1.  Productive Cytomegalovirus Infection Is Associated With Impaired Endothelial Function in ST-Elevation Myocardial Infarction.

Authors:  Anna Lebedeva; Elena Maryukhnich; Jean-Charles Grivel; Elena Vasilieva; Leonid Margolis; Alexander Shpektor
Journal:  Am J Med       Date:  2019-07-08       Impact factor: 4.965

Review 2.  Human Cytomegalovirus Induced Aberrant Expression of Non-coding RNAs.

Authors:  Zhongjie Yu; Jing Wang; Fulong Nan; Wenyi Shi; Xianjuan Zhang; Shasha Jiang; Bin Wang
Journal:  Front Microbiol       Date:  2022-06-13       Impact factor: 6.064

Review 3.  Human cytomegalovirus (HCMV)-encoded microRNAs: potential biomarkers and clinical applications.

Authors:  Raquel Fernández-Moreno; Julián Torre-Cisneros; Sara Cantisán
Journal:  RNA Biol       Date:  2021-05-26       Impact factor: 4.766

Review 4.  MicroRNAs expressed by human cytomegalovirus.

Authors:  Lichen Zhang; Jiaqi Yu; Zhijun Liu
Journal:  Virol J       Date:  2020-03-12       Impact factor: 4.099

5.  MicroRNA‑1929‑3p participates in murine cytomegalovirus‑induced hypertensive vascular remodeling through Ednra/NLRP3 inflammasome activation.

Authors:  Wei Zhou; Dongmei Xi; Yunzhong Shi; Lamei Wang; Hua Zhong; Zhen Huang; Yongmin Liu; Yan Tang; Ning Lu; Yongjia Wang; Zhengyu Zhang; Jiaxin Pei; Na Tang; Fang He
Journal:  Int J Mol Med       Date:  2020-12-22       Impact factor: 4.101

Review 6.  The Role of CMV Infection in Primary Lesions, Development and Clinical Expression of Atherosclerosis.

Authors:  Carmen Valentina Cristescu; Sophie Alain; Simona Maria Ruță
Journal:  J Clin Med       Date:  2022-07-01       Impact factor: 4.964

7.  Cytomegalovirus microRNAs level determination in kidney recipients post transplantation.

Authors:  Afsoon Afshari; Ramin Yaghobi; Mehdi Golshan
Journal:  Virol J       Date:  2022-09-12       Impact factor: 5.913

8.  Expression of human miR-200b-3p and -200c-3p in cytomegalovirus-infected tissues.

Authors:  Kyoung Hwa Lee; Beom Jin Lim; Victor H Ferreira; Seo Yeon Min; Yeon-Mi Hong; Jeong-Hyeon Jo; Sang Hoon Han
Journal:  Biosci Rep       Date:  2018-12-07       Impact factor: 3.840

Review 9.  Non-Coding RNAs: Strategy for Viruses' Offensive.

Authors:  Alessia Gallo; Matteo Bulati; Vitale Miceli; Nicola Amodio; Pier Giulio Conaldi
Journal:  Noncoding RNA       Date:  2020-09-10

10.  Proteomics changes after negative pressure wound therapy in diabetic foot ulcers.

Authors:  Zeguo Jia; Lei Liu; Shiqian Zhang; Xiaotong Zhao; Li Luo; Yizhong Tang; Bing Shen; Mingwei Chen
Journal:  Mol Med Rep       Date:  2021-10-05       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.